Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway
2009 StandoutNobel
Neuropsychological Risk Indicators for Schizophrenia: A Review of Family Studies
1994
Haloperidol dose for the acute phase of schizophrenia
2002
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
1993
Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients
2009
G Protein-Coupled Receptor Kinase Function Is Essential for Chemosensation in C. elegans
2004 StandoutNobel
Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement?
2004
Linkage and associated studies of schizophrenia
2000
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Descending control of pain
2002 Standout
The effects of leptin on REM sleep and slow wave deltain rats are reversed by food deprivation
1999
Schizophrenia
2009 Standout
Molecular pharmacological aspects of histamine receptors
1995
The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms
2001
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
2006 StandoutNobel
Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat
1995
Polymorphisms in dopamine receptors: what do they tell us?
2000
Pedunculopontine nucleus in the squirrel monkey: Distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons
1994
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia
1993
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Mapping brain maturation
2006 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Endoplasmic reticulum stress in wake‐active neurons progresses with aging
2011
G-Protein-coupled receptors in HL-60 human leukemia cells
1996
Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype
2003
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
Ion‐selective membranes with low plasticizer content: Electroanalytical characterization and biocompatibility studies
1994
Efficient adenylyl cyclase activation by a β2-adrenoceptor-Giα2 fusion protein
2002 StandoutNobel
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies
2000
Volume regulation in human fibroblasts: role of Ca2+ and 5-lipoxygenase products in the activation of the Cl? efflux
1993
ABCB1 and Cytochrome P450 Polymorphisms
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Neurotoxicity, Neuroplasticity, and Magnetic Resonance Imaging Morphometry
2002
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Effect of nucleotides on the cytosolic free calcium activity and inositol phosphate formation in human glomerular epithelial cells
1992
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
Toward Reformulating the Diagnosis of Schizophrenia
2000
Cell Biology of the Glomerular Podocyte
2003 Standout
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
1996 Standout
Nicotine replacement therapy for smoking cessation
2012 Standout
Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
1995 Standout
Serotonin-containing neuronal perikarya in the primate locus coeruleus and subcoeruleus
1977
Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals
1981 Standout
Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene,PPP3CC, encoding the calcineurin gamma subunit
2003 Nobel
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 1. General Characteristics
1997 Standout
Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors
1985 Standout
New neutral carrier-based H+ selective membrane electrodes
1992
Increased Acute Inflammation, Leukotriene B4-Induced Chemotaxis, and Signaling in Mice Deficient for G Protein-Coupled Receptor Kinase 6
2003 StandoutNobel
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
How antipsychotics work—From receptors to reality
2006
Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
2005 StandoutNobel
Haloperidol dose for the acute phase of schizophrenia
2013
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Postmortem studies in schizophrenia
2000
The molecular, physical and mechanical properties of highly plasticized poly(vinyl chloride) membranes
1993
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
THE BASAL GANGLIA: FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMS
1996 Standout
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation
2002
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 2. Ionophores for Potentiometric and Optical Sensors
1998 Standout
The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem
1983
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Age-Related Reduction of Recovery Sleep and Arousal Threshold inDrosophila
2016 StandoutNobel
Dopamine Metabolism in the Cerebrospinal Fluid of Drug-Free Schizophrenic Patients With and Without Cortical Atrophy
1986
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of D. Garver being referenced
The epidemiology of prosthetic heart valves in the United States.
1995
Atrophic and Static (Neurodevelopmental) Schizophrenic Psychoses Premorbid Functioning, Symptoms and Neuroleptic Response
1999
Brain and ventricle instability during psychotic episodes of the schizophrenias
2000
Etiologic Heterogeneity of the Psychoses: Is There a Dopamine Psychosis?
1997
Heterogeneity of the Psychoses: Is There a Neurodegenerative Psychosis?
1998
When Symptoms Persist: Clozapine Augmentation Strategies
2001
Report of the Chromosome 5 Workshop of the Sixth World Congress on Psychiatric Genetics
1999
Methodological Issues Facing the Interpretation of High-risk Studies: Biological Heterogeneity
1987
A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients.
1983
Histamine receptors in human fibroblasts: inositol phosphates, Ca2+, and cell growth
1990
Down-regulation of central dopamine receptors in schizophrenia
1985
Certain biochemical correlates of intense serotonin histofluorescence in the brain stem of the neonatal monkey
1974
Postsynaptic supersensitivity in schizophrenia
1977
Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients
1991
Negative symptoms of familial schizophrenia breed true in unstable (vs. stable) cerebral-ventricle pedigrees
1999
Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder
1987
Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophrenia
1982
Monoamine distribution in primate brain—IV. Indoleamine-containing perikarya in the brain stem of Macaca arctoides
1982
Chromosomes 1, 2, and 7 workshop
1999
Beta-adrenergic receptor function in affective illness
1979